View in EDS HTML Full Text PDF Full Text

Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era.

Saved in:
Bibliographic Details
Title: Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era.
Authors: McCreary, Erin K1 (AUTHOR) mccrearye3@upmc.edu, Kip, Kevin E2 (AUTHOR), Collins, Kevin2 (AUTHOR), Minnier, Tami E3 (AUTHOR), Snyder, Graham M1 (AUTHOR), Steiner, Ashley4 (AUTHOR), Meyers, Russell4 (AUTHOR), Borneman, Tina5 (AUTHOR), Adam, Michelle4 (AUTHOR), Thurau, Lauren4 (AUTHOR), Yealy, Donald M4 (AUTHOR), Huang, David T4,6 (AUTHOR), Bariola, J Ryan1 (AUTHOR), Schmidhofer, Mark7 (AUTHOR), Wadas, Richard J4 (AUTHOR), Angus, Derek C6 (AUTHOR), Kip, Paula L3 (AUTHOR), Marroquin, Oscar C2 (AUTHOR)
Source: Open Forum Infectious Diseases. Oct2022, Vol. 9 Issue 10, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23288957
DOI:10.1093/ofid/ofac517